Collectively, these tumor-inhibitory roles attributed to SIRT7 are mainly tissue specific and context dependent and are of a secondary nature, which warrants more detailed investigation before establishing SIRT7 as a key molecular target in cancer (FIGURE 12). Here, SIRT7 is linked to cancer.